Does Geisinger Health Plan Cover Mounjaro?
The verdict
Conditional on most plans
Geisinger Health Plan covers Mounjaro for type 2 diabetes with prior authorization across commercial, ACA, and Medicare Part D lines. Mounjaro is not covered for weight loss under any Geisinger line. The weight-loss tirzepatide product is Zepbound, with separate and often-excluded coverage. Pennsylvania Medicaid dropped adult weight-loss GLP-1s in 2025, so Geisinger Medicaid is diabetes-only. Verify tier and prior-auth criteria on the Geisinger formulary.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Geisinger Health Plan using your member ID.
Key facts
Mounjaro (tirzepatide) is FDA-approved for type 2 diabetes only — not weight loss. The weight-loss tirzepatide product is Zepbound, a separate FDA approval.
FDA drug labeling, Mounjaro (tirzepatide) prescribing information
Pennsylvania Medicaid dropped adult weight-loss GLP-1 coverage in 2025, affecting all PA health plans including Geisinger — diabetes coverage for Mounjaro was not affected.
Pennsylvania Department of Human Services, Medicaid PDL update 2025
The 2026 Medicare Part D out-of-pocket cap is $2,100; most continuous Mounjaro users for diabetes reach the cap within 2–3 months and pay $0 for the rest of the year.
CMS.gov, Medicare Part D Redesign 2025–2026
Medicare vs. commercial coverage
Whether Geisinger Health Plan covers Mounjaro depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Part D covers Mounjaro for type 2 diabetes only — not weight loss — at a specialty or non-preferred tier with prior authorization. The 2026 out-of-pocket cap is $2,100; most continuous users reach it within 2–3 months and pay $0 for the remainder of the year. The IRA-negotiated Medicare MFN price of $245/month begins mid-2026. Mounjaro is NOT included in the 2026 Medicare GLP-1 Bridge demonstration ($50/month, July 1, 2026 – Dec 31, 2027), which covers weight-loss-approved products only. Lilly savings card is not usable by Medicare beneficiaries. Verify your specific Geisinger Medicare plan formulary each year.
Commercial / Employer
Group & marketplace plans
Commercial and employer-sponsored Geisinger plans cover Mounjaro for type 2 diabetes with prior authorization; off-label weight-loss use (diagnosis code E66.x) is denied. ACA/Individual plans cover Mounjaro for T2D with PA; weight-loss GLP-1s are commonly excluded. Pennsylvania Medicaid (covered by Geisinger) dropped adult weight-loss GLP-1s in 2025 — Mounjaro remains covered for T2D with PA at nominal cost-share. Commercially insured patients with coverage may pay as little as $25/month via the Lilly savings card (excludes Medicare, Medicaid, and government programs; card expires 12/31/2026). Without coverage on a commercial plan, the card reduces cost to $499/month (max $647/month, up to 13 fills). Verify tier and cost-share on the Geisinger formulary or member services.
The 5 boxes you must tick to get approved
Commercial plans that will consider Mounjaro require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Mounjaro actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Approximately $1,300–$1,560/month retail (WAC ~$1,080). Lilly savings card: $499/month for commercially insured without coverage (max $647/month, up to 13 fills; expires 12/31/2026). Excludes all government programs.
List price with no coverage — before any manufacturer savings card.
With coverage
Varies by plan tier — verify on Geisinger formulary or member services. Commercially insured patients with coverage may pay as little as $25/month via the Lilly savings card.
Typical monthly copay once prior authorization is approved.
Bridge program
Lilly Mounjaro Savings Card: commercially insured patients with coverage as little as $25/mo for 1–3 month supply; without coverage $499/mo (up to 13 fills, expires 12/31/2026). Not available to Medicare, Medicaid, Medicare Advantage, or government program beneficiaries.
Reduced copay through the assistance program, where eligible.
All figures are estimates; actual cost-share varies by plan tier, pharmacy, and deductible status. Confirm with Geisinger formulary or member services. Medicare Part D: 25% coinsurance after deductible until the $2,100 OOP cap; MFN $245/month mid-2026. PA Medicaid nominal cost-share.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Search the Geisinger formulary or drug list
Visit Geisinger Health Plan's member portal or formulary search tool and enter 'Mounjaro' or 'tirzepatide.' Confirm the tier, prior authorization requirement, and cost-share for your specific plan type (commercial, Medicare, or Medicaid).
- 2
Have your prescriber prepare the prior authorization
Your prescriber will need to document your confirmed T2D diagnosis (ICD-10 E11.x), an A1c of 6.5% or higher within roughly 90 days, and a trial or documented failure of metformin. Geisinger is a provider-owned integrated plan in central and northeastern Pennsylvania — your Geisinger physician may be able to initiate the PA directly within the integrated system.
- 3
Call Geisinger member services if coverage is unclear
Call the member services number on the back of your Geisinger card and ask: Is Mounjaro covered for type 2 diabetes on my plan? What tier? Is prior authorization required? What is my estimated cost-share? Because Geisinger's formulary is not as widely published as national carriers, confirming directly with the plan is especially important.
Options if Geisinger Health Plan won't cover Mounjaro
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Ozempic (semaglutide)
FDA-approved for type 2 diabetes. Widely covered with prior authorization across PA commercial and Medicaid plans; often placed ahead of Mounjaro in step-therapy sequences.
Trulicity (dulaglutide)
FDA-approved for T2D. GLP-1 alternative; often preferred tier with lower list price than Mounjaro. Verify on Geisinger formulary.
Jardiance (empagliflozin) or Farxiga (dapagliflozin)
SGLT2 inhibitors approved for T2D with cardiovascular and renal benefits. May be part of step-therapy requirements before GLP-1 approval.
Zepbound (tirzepatide) — weight loss only
Same molecule as Mounjaro but FDA-approved for chronic weight management and obstructive sleep apnea — not diabetes. Has separate coverage from Mounjaro. Pennsylvania Medicaid dropped adult weight-loss GLP-1s in 2025, affecting Zepbound access on the Medicaid line.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. Geisinger does not cover Mounjaro for weight loss. Mounjaro is FDA-approved for type 2 diabetes only, and off-label weight-loss prescriptions coded with obesity diagnoses are denied. The weight-loss tirzepatide product is Zepbound, which is FDA-approved for chronic weight management and has separate coverage. Pennsylvania Medicaid also dropped adult weight-loss GLP-1s in 2025. Verify any weight-loss GLP-1 coverage on the Geisinger formulary.
No. Pennsylvania Medicaid dropped adult weight-loss GLP-1 coverage in 2025. Geisinger's Medicaid line follows the state PDL, so weight-loss GLP-1s (including Zepbound) are no longer covered for adult weight management. Mounjaro is covered for type 2 diabetes — this change does not affect diabetes coverage — but anyone seeking tirzepatide for weight loss on Geisinger Medicaid will be denied.
Geisinger's PA for Mounjaro typically requires a confirmed type 2 diabetes diagnosis (ICD-10 E11.x), A1c of 6.5% or greater within roughly 90 days, and a trial or documented failure of metformin (plus often one additional oral agent). Age 18 or older is required. Quantity limit is typically 4 pens per 28 days. Verify the specific Geisinger criteria on the plan formulary — as a provider-owned integrated plan, criteria may differ from national PBM defaults.
Yes, if you have commercial Geisinger coverage and Mounjaro is covered on your plan, you may pay as little as $25/month via the Lilly savings card. Without commercial coverage, the card reduces cost to $499/month (max $647/month, up to 13 fills, expires 12/31/2026). The card is not available to Medicare Part D, Medicare Advantage, Medicaid, or any government program beneficiaries — including Geisinger Medicaid enrollees.
No. The 2026 Medicare GLP-1 Bridge ($50/month copay, July 1, 2026 – December 31, 2027) covers weight-loss-approved products only — Wegovy, Foundayo, and the Zepbound KwikPen. Mounjaro is excluded from the Bridge because it is a diabetes drug. Medicare covers Mounjaro for type 2 diabetes under standard Part D with prior authorization, specialty-tier cost-share, and the $2,100 annual OOP cap.
Related Articles
Does Security Health Plan Cover Mounjaro? 2026 | Curex
Security Health Plan (WI) covers Mounjaro for type 2 diabetes with prior auth — not weight loss. Composite pattern; verify on plan formulary.
Read moreDoes Tufts Health Plan Cover Mounjaro? 2026 Guide | Curex
Tufts Health Plan covers Mounjaro for type 2 diabetes with prior auth — not weight loss. MA Medicaid covers diabetes; weight-loss GLP-1s restricted.
Read moreDoes Quartz Health Solutions Cover Ozempic? 2026 | Curex
Quartz Health Solutions covers Ozempic for type 2 diabetes with prior auth — not weight loss. Wisconsin regional plan; verify tier on Quartz member portal.
Read moreDoes Health Net Cover Ozempic? 2026 Coverage Guide | Curex
Health Net covers Ozempic for type 2 diabetes with prior auth — not weight loss. Medi-Cal T2D covered. Verify tier on Health Net drug lookup tool.
Read moreDoes Harvard Pilgrim Health Care Cover Mounjaro? 2026 | Curex
Harvard Pilgrim (Point32Health) covers Mounjaro for type 2 diabetes with PA — not weight loss. MA Medicaid covers diabetes; weight-loss GLP-1s restricted.
Read moreDoes UPMC Health Plan Cover Mounjaro? 2026 | Curex
UPMC Health Plan covers Mounjaro for type 2 diabetes with prior auth in western PA — not weight loss. PA Medicaid cut weight-loss GLP-1s in 2025.
Read moreInsurance covers Mounjaro only for diabetes — for weight loss, here's a path that skips insurance
Geisinger covers Mounjaro for diabetes only, not weight loss, and PA Medicaid dropped adult weight-loss GLP-1s in 2025. For patients who want tirzepatide access without insurance, compounded tirzepatide from $149/mo (and compounded semaglutide from $49/mo) is available at getcurex.com/cl/glp — no insurance required, no prior authorization. This is compounded tirzepatide and is not the same medication as Mounjaro or Zepbound. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Mounjaro and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Geisinger Health Plan before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Mounjaro and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.